Concepedia

Jim Valentine

JV

Statistics

Publications

5

Citations

163

H-Index

5

Active since

1988

Affiliations

Vion Pharmaceuticals (United States)(Current)

Cayman Chemical (United States)

Jim Valentine is an author at Vion Pharmaceuticals (United States) specializing in pharmacology, drug discovery, and enzyme inhibition.

Publications per year

1988–2016

5

Publications

5

Heritage Language Research Priorities Conference Report

Russell Campbell, Shōichi Iwasaki, Olga Kagan et al. · 2001 · 61 citations

, , +11

Seeding with endothelial cells derived from the microvessels of the omentum and from the jugular vein: A comparative study

Antonio V. Sterpetti, William J. Hunter, Richard D. Schultz et al. · Journal of Vascular Surgery · 1988 · 43 citations · Full text

, , +7

Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors

Daniel R. Goldberg, Stéphane De Lombaert, Robert J. Aiello et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 33 citations · Full text

, , +11

Discovery of acyl guanidine tryptophan hydroxylase-1 inhibitors

Daniel R. Goldberg, Stéphane De Lombaert, Robert J. Aiello et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 14 citations · Full text

, , +11

Staff views on the extended role of health care assistants in the critical care unit

Jenny Sutton, Jim Valentine, Kim Rayment · Intensive and Critical Care Nursing · 2004 · 12 citations

, , +14

1–5 of 5